DCISionRT® Registry

Prospective registry to evaluate the effect of the DCISionRT® test on treatment decisions in patients with Ductal Carcinoma In Situ (DCIS) following breast conserving surgery.

Eligibility criteria

To be considered for this registry you must meet the following criteria:

Study details

Your participation in this registry means information will be collected about your diagnosis, test result (which will be shared with your doctor and radiation oncologist), treatment and outcomes over a 5-year period.  In addition your results, only when de-identified, could be used for future medical research by PreludeDx and GenesisCare. Such research may involve the investigation of new methods of diagnosis and treatment, the development of new products, treatment pathways and patient management processes aimed at improving outcomes for patients like you.

More information

For further information contact: